COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine.

Veerman, Selene R T; Bogers, Jan P A M; Cohen, Dan; Schulte, Peter F J

Veerman, Selene R T; Bogers, Jan P A M; Cohen, Dan; Schulte, Peter F J.

Afiliación

Veerman SRT; MHO Noord-Holland Noord and the Dutch Clozapine Collaboration Group, Netherland.
Bogers JPAM; MHO Rivierduinen and the Dutch Clozapine Collaboration Group, Netherland.
Cohen D; MHO Noord-Holland Noord and the Dutch Clozapine Collaboration Group, Netherland.
Schulte PFJ; MHO Noord-Holland Noord and the Dutch Clozapine Collaboration Group, Netherland.

Pharmacopsychiatry ; 55(1): 48-56, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34470068

Asunto(s)

Antipsicóticos; COVID-19; Clozapina; Esquizofrenia; Antipsicóticos/efectos adversos; Clozapina/efectos adversos; Humanos; SARS-CoV-2; Esquizofrenia/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacopsychiatry Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google